Literature DB >> 21637988

Risk factors for chronic kidney diseases may include periodontal diseases, as estimated by the correlations of plasma pentraxin-3 levels: a case-control study.

A R Pradeep1, Rahul Kathariya, P Arjun Raju, R Sushma Rani, Anuj Sharma, N M Raghavendra.   

Abstract

BACKGROUND: Pentraxins are classical mediators of inflammation and markers of acute-phase reactions. Pentraxin-3 (PTX3) is believed to be a true independent indicator of disease activity. It has been associated with clinical outcomes in incident chronic kidney disease (CKD) and periodontal diseases. Periodontitis is lately being considered as a risk factor for CKD. However, no data are available on elevated PTX3 in patients with CKD associated with periodontitis.
METHOD: Sixty subjects were divided into three groups (n = 20) based on glomerular filtration rate (GFR) and periodontal parameters: healthy (group-1), CKD (group-2), and CKD with periodontitis (group-3). Plasma samples obtained from each patient were quantified for PTX3 using Enzyme-linked Immunosorbent Assay (ELISA).
RESULTS: Both patient groups with CKD had higher plasma PTX3 concentrations than control subjects. However, there was no significant difference between the two groups (groups 2 and 3). In all groups, plasma PTX3 correlated positively with periodontal parameters. Group 3 patients had higher concentrations of PTX3 (6.338 ng/ml) than group 2 (5.41 ng/ml) and group 1 (1.835 ng/ml).
CONCLUSIONS: Within the limits of the present study, the difference in plasma PTX3 levels between groups 2 and 3 was not found to be statistically significant (P > 0.05). However, as PTX3 values correlated positively with periodontal parameters, this model could contribute to identifying individuals with periodontitis at high risk of CKD. Thus, periodontal disease could serve as a risk factor for developing CKD. Further large-scale studies nullifying the confounders for CKD are warranted to confirm positive results.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21637988     DOI: 10.1007/s11255-011-9997-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  55 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans.

Authors:  G Peri; M Introna; D Corradi; G Iacuitti; S Signorini; F Avanzini; F Pizzetti; A P Maggioni; T Moccetti; M Metra; L D Cas; P Ghezzi; J D Sipe; G Re; G Olivetti; A Mantovani; R Latini
Journal:  Circulation       Date:  2000-08-08       Impact factor: 29.690

Review 3.  Systemic humoral immune responses in periodontal disease.

Authors:  J L Ebersole
Journal:  Crit Rev Oral Biol Med       Date:  1990

4.  Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.

Authors:  Irene Cetin; Veronica Cozzi; Fabio Pasqualini; Manuela Nebuloni; Cecilia Garlanda; Luca Vago; Giorgio Pardi; Alberto Mantovani
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

Review 5.  Preventing chronic kidney disease in special populations.

Authors:  Kenneth A Jamerson
Journal:  Am J Hypertens       Date:  2005-04       Impact factor: 2.689

6.  Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis.

Authors:  Ai Yano; Kazushi Nakao; Ai Sarai; Shigeru Akagi; Takashi Kihara; Hisanori Morimoto; Akihiko Nakamura; Makoto Hiramatsu; Yoshio Nagake; Hirofumi Makino
Journal:  Nephrology (Carlton)       Date:  2005-12       Impact factor: 2.506

7.  PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation.

Authors:  F Fazzini; G Peri; A Doni; G Dell'Antonio; E Dal Cin; E Bozzolo; F D'Auria; L Praderio; G Ciboddo; M G Sabbadini; A A Manfredi; A Mantovani; P R Querini
Journal:  Arthritis Rheum       Date:  2001-12

8.  Increased expression of long pentraxin PTX3 in inflammatory bowel diseases.

Authors:  Shingo Kato; Mitsuko Ochiai; Tomoya Sakurada; Shino Ohno; Kyoko Miyamoto; Mina Sagara; Masataka Ito; Kyoko Takeuchi; Junko Imaki; Kazuro Itoh; Koji Yakabi
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

9.  Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.

Authors:  Mengli Tong; Juan Jesús Carrero; A Rashid Qureshi; Björn Anderstam; Olof Heimbürger; Peter Bárány; Jonas Axelsson; Anders Alvestrand; Peter Stenvinkel; Bengt Lindholm; Mohamed E Suliman
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-16       Impact factor: 8.237

10.  Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes.

Authors:  V V Alles; B Bottazzi; G Peri; J Golay; M Introna; A Mantovani
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113

View more
  6 in total

1.  PTX3 in serum induces renal mesangial cell proliferation but has no effect on apoptosis.

Authors:  Danhuan Zhang; Minhui Xi; Lingyun Chen; Yanping Huang; Peiju Mao
Journal:  Exp Ther Med       Date:  2017-11-16       Impact factor: 2.447

2.  Biochemical analysis of pentraxin 3 and fibrinogen levels in experimental periodontitis model.

Authors:  Gonca Cayir Keles; Umut Balli; Burcu Ozkan Cetinkaya; Bulent Ayas; Arzu Findik; Zeynep Pinar Keles; Ferda Pamuk
Journal:  Mediators Inflamm       Date:  2012-08-15       Impact factor: 4.711

3.  Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.

Authors:  Kenji Daigo; Takao Hamakubo
Journal:  Front Immunol       Date:  2012-12-13       Impact factor: 7.561

Review 4.  Resistin: a potential biomarker for periodontitis influenced diabetes mellitus and diabetes induced periodontitis.

Authors:  Archana Devanoorkar; Rahul Kathariya; Nagappa Guttiganur; D Gopalakrishnan; Paulami Bagchi
Journal:  Dis Markers       Date:  2014-02-12       Impact factor: 3.434

5.  Risk factors for chronic kidney disease: an update.

Authors:  Rumeyza Kazancioğlu
Journal:  Kidney Int Suppl (2011)       Date:  2013-12

Review 6.  On the occasion of world kidney day 2017; obesity and its relationship with chronic kidney disease.

Authors:  Leila Mahmoodnia; Mohammad Reza Tamadon
Journal:  J Nephropathol       Date:  2017-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.